San Francisco, 25 September
2018: According to a report by Grand View Research, Inc., global novel
drug delivery systems (NDDS) in cancer therapy market is
anticipated to value USD 26.61 billion by 2025. Growing requirement for
advanced medical devices to avail better treatment is anticipated to propel
demand for novel drug delivery systems. These systems are likely to protect
drugs essential for cancer treatment from enzymatic and chemical
degradation.
Growing need for cancer
therapeutic drugs owing to rising cases of cancer is expected to influence
growth of market. Spreading awareness among patients regarding availability of
alternative methods of cancer treatments can stimulate market growth. Rising cases of cancer owing to unhealthy
lifestyle is anticipated to influence growth of market. Increasing R&D
investments to expand product pipeline and for regulatory approvals of new products
can influence market growth. Supportive reimbursement scenarios in developed
nations coupled with availability of research funding is likely to augment
market growth during the forecast period (2014 to 2025).
The NNDS in cancer therapy
market can be segregated on the basis of product and region. Based on product,
the market can be categorized into embolization particles and nanoparticles. In
2016, nanoparticles segment dominated the market and accounted of largest
market share. It is anticipated to grow at similar pace during the forecast period.
These type of drug delivery systems are expected to encapsulate various drugs
and protect them from enzymatic and chemical degradation. In addition, they can
provide long circulation half-lives, improved pharmacokinetics and reduced side
effects. Moreover, these systems can also offer enhanced permeability to allow
efficient delivery of drugs to cancer tissues.
Access
Research Report of Novel
Drug Delivery Systems in Cancer Therapy Market@ www.grandviewresearch.com/industry-analysis/novel-drug-delivery-systems-in-cancer-therapy
Based on aforementioned
properties, nanoparticles can replace conventional chemotherapy treatment
attributed to less risk to healthy tissues and high efficiency. Nanoparticles
can be categorized into micelles, liposomes, polymers, and other nanoparticles.
Micelles and liposomes are likely to be used for DNA delivery & targeting
and can increase drug efficacy. In 2016, liposomes segment held for largest
market share under nanoparticles segment. It is expected to grow at similar
pace during the forecast period.
On the contrary, embolization
particles segment can be classified further into liquid emboli, PVA particles,
drug eluting beads, and other embolization particles. These particles can be
injected into small vessels providing blood to cancer cells. Such procedures
can allow easy surgical reception of cancer cells resulting from reduced blood
loss.
Regional segmentation includes
Europe, North America, Asia Pacific, Latin America, and Middle East and Africa.
In 2016, North America region dominated the market and accounted for 36.8% revenue
share. Increasing number of research activities to develop new therapies can
fuel growth of market in the region. In addition, growing awareness
availability of novel drugs attributed to promotional and marketing activities
of manufacturers is anticipated to propel market growth. Moreover, growing
budget for novel drug discovery coupled with increasing number of food and drug
administration (FDA) approvals can also fuel market growth in the region.
Browse more reports of this category by
Grand View Research at: www.grandviewresearch.com/industry/medical-devices
On the contrary, European
market followed North America and stood second in terms of revenue share in
2016. It is expected to witness significant growth during the forecast period
attributed to growing healthcare expenditure. High prevalence of cancer
patients coupled with rise in research funding for cancer treatments can fuel
market growth. Many local organizations in United Kingdom and Germany are
expected to fund new technologies, which in turn can influence market growth in
the region.
In Asia Pacific, the market is
expected to grow at fastest rate during the forecast period. Rising cases of
cancer in China and Japan owing to increasing geriatric population can
stimulate market growth. In addition, increasing number of research activities
coupled with growing awareness regarding availability of new cancer therapies
can augment growth of market in the region.
Some of the leading companies
offering NNDS in cancer therapy are Merrimack Pharmaceuticals, Inc.; Teva
Pharmaceutical Industries Limited; Johnson & Johnson Services, Inc.;
Samyang Biopharmaceuticals Corporation; and Celgene Corporation. Geographic
expansions, frequent product launches, and distribution agreements to increase
customer base are likely to be key strategies players can undertake to expand
their market share. In addition, companies are likely to invest in R&D
activities to develop new and innovative NDDS systems in cancer therapy to
expand their product portfolio.
Access
Press Release of Novel Drug Delivery Systems in Cancer Therapy Market@ www.grandviewresearch.com/press-release/global-novel-drug-delivery-systems-in-cancer-therapy-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based
research across a range of industries, from technology to chemicals, materials
and healthcare.
No comments:
Post a Comment